arrow
D

Daniela Massi

university zurich hospital
H指数:65
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

WHO classification of skin tumours: key updates in the fifth edition

WHO皮肤肿瘤分类:第五版关键更新

2025-11-010
OAAI
Evaluation of Sonidegib Cytoreductive Activity in Locally Advanced Basal Cell Carcinoma Treatment: A Delphi Consensus

评估Sonidegib在局部晚期基底细胞癌治疗中的细胞减灭活性:一项Delphi共识

2025-10-210
PRE
EGFR Mutation Detection in Whole Slide Images of Non-Small Cell Lung Cancers Using a Two-Stage Deep Transfer Learning Approach

非小细胞肺癌全切片图像中EGFR突变检测:一种两阶段深度迁移学习方法

2025-09-180
OAAI
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis

原发性和转移性配对黑色素瘤样本的肿瘤微环境异质性及其与遗传特征和预后的相关性

2025-09-080
PRE
Clinical, Histopathological, Dermoscopic Features, and BRAF, NRAS, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma

临床、组织病理学、皮肤镜特征,以及皮肤黑色素瘤中BRAF、NRAS和细胞周期基因的突变状态

2025-08-200
PRE
Cutaneous melanoma

皮肤黑色素瘤

2025-04-030
PRE
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region

揭示头颈部粘膜黑色素瘤的分子景观和临床相关分子异质性

2025-04-010
PRE
Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results
2024-12-010
OAAI
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)
2024-11-011
OAAI
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study

意大利中部托斯卡纳人利什曼病的兴起: 一项多中心研究的临床和流行病学数据

2024-09-271
OAAI
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

抗PD-1疗法在儿童和青少年黑色素瘤患者中的疗效(MELCAYA研究)

2024-09-010
PRE
Primary analysis of the EORTC 1208 Minitub trial: Prospective registry of sentinel node (SN) positive melanoma patients with minimal SN tumor burden

EORTC 1208 Minitub试验的初步分析:前瞻性登记研究,针对哨兵淋巴结(SN)阳性的黑色素瘤患者且具有最低限度SN肿瘤负荷。

2024-09-010
PRE
SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors
2024-03-019
OAAI